The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Cleerly Secures 106 Million for AI Driven Heart Disease Detection Technology
Cleerly, a cardiovascular imaging startup, has raised $106 million in a Series C extension round led by Insight Partners to enhance its AI-driven heart disease detection technology. Founded by cardiologist James Min, the company aims to identify early-stage coronary artery disease through CT scans, potentially transforming heart health screening. With Medicare's recent approval for its plaque analysis test, Cleerly is positioned for significant growth as it seeks regulatory approval for broader screening applications.